Rizatriptan-Naproxen combination

· Eurofarma Laboratorios S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rizatriptan-Naproxen combination, covering 2025-02-14 to 2025-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Rizatriptan-Naproxen (10/550 Mg) in the Acute Treatment of Migraine [Phase 3]